Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Medicare Part D
Payers
OIG: Jury still out on vertical consolidation's impact in Part D
An analysis from the Office of Inspector General found similar net cost for drugs through vertically-integrated Part D plans compared to other plans.
Paige Minemyer
May 19, 2026 11:58am
CMS delays Part D GLP-1 model amid skepticism from insurers
Apr 22, 2026 12:00pm
CMS locks in MA star ratings overhaul for FY2027
Apr 2, 2026 5:45pm
KFF: A look at Part D enrollment trends for 2026
Mar 6, 2026 4:40pm
CMS launching payment model to boost access to GLP-1s
Dec 24, 2025 6:20am
CMMI proposes new models to lower drug prices in Parts B, D
Dec 22, 2025 12:00pm
